Phase 2 is approaching, the reformulation has over come a huge obstacle that stops many a promising cancer project in its tracks, the Olivia Newton John Cancer Research Centre is getting positive results in its lab experiments against human tumours, income from the Epichem division is up, and the stock, though still dirt cheap, is finally awaking from its long coma, and BOOM, out of nowhere come the DOWN RAMPERS WE NEVER HEARD OF SPEWING FUD even before the trial begins. Well, well, well, what a surprise...oh wait
Ann: Investor Presentation, page-9
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
-0.010(5.00%) |
Mkt cap ! $95.88M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.0¢ | $106.3K | 547.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 593393 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 33456 | 3 |
View Market Depth
| Last trade - 15.22pm 12/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |